[Rapporto di ricerca] Si prevede che il mercato dei servizi di metabolomica raggiungerà 1.895,14 milioni di dollari entro il 2028 rispetto a 501,24 milioni di dollari nel 2021; si stima che crescerà a un CAGR del 20,9% dal 2021 al 2028.
La metabolomica è lo studio e l'analisi dei processi biologici che coinvolgono intermedi e sottoprodotti metabolici: i metabolomi. I metabolomi includono metaboliti secondari, molecole di segnalazione, ormoni e intermedi metabolici.
Approfondimenti strategici
Il rapporto offre un'analisi approfondita dei mercato dei servizi di metabolomica, sottolineando le tendenze del mercato, i progressi tecnologici, le dinamiche del mercato e il panorama competitivo (che coinvolge i principali attori del mercato in tutto il mondo). Include anche l’impatto della pandemia COVID-19 sul mercato in tutte le principali regioni. Il Nord America detiene la quota di mercato maggiore e la crescita del mercato in questa regione è attribuita all’elevata consapevolezza e accettazione dei servizi di metabolomica, al crescente numero di vendite al dettaglio online e al crescente numero di innovazioni e lanci di prodotti. Inoltre, è probabile che anche la crescente spesa da parte delle società di tecnologia sessuale abbia un impatto positivo sul mercato dei servizi di metabolomica del Nord America durante il periodo di previsione. Il mercato, per regione, è segmentato in Nord America, Europa, Asia Pacifico (APAC), Medio Oriente e Africa (MEA) e America meridionale e centrale (SAM).
Regioni redditizie per il mercato dei servizi di metabolomica
Approfondimenti di mercato
L'aumento dell'incidenza del cancro alimenta la metabolomica Crescita del mercato dei servizi
La metabolomica è una delle tecnologie robuste e in crescita per il rilevamento di un'ampia gamma di metaboliti nei tessuti e nei biofluidi. Questo processo ha un'applicazione significativa nell'analisi e negli studi associati alle malattie del cancro. Si prevede che la crescente prevalenza di diversi tipi di cancro guiderà il mercato durante il periodo di previsione. La diagnostica del cancro svolge un ruolo essenziale nel trattamento del cancro. Secondo i dati pubblicati dall’Organizzazione Mondiale della Sanità (OMS) nel settembre 2021, quasi il 70% dei decessi per cancro sono stati segnalati nei paesi a basso e medio reddito di tutto il mondo. La quota globale totale di incidenza del cancro secondo i dati del Global Cancer Observatory riguarda il seno (2,26 milioni di casi 11,7%), il polmone (2,21 milioni di casi 11,4%), il colon e il retto (1,93 milioni di casi 10%), la prostata (1,41 milioni di casi 7,3%), stomaco (1,09 milioni di casi 5,6%). Di seguito sono riportati i dettagli relativi alla prevalenza regionale nel 2020:
Approfondimenti basati sul tipo di servizio
Il mercato dei servizi di metabolomica, in base al tipo di servizio, è stato segmentato in servizio di metabolomica mirato e servizio di metabolomica non mirato. È probabile che il segmento dei servizi di metabolomica mirato deterrà una quota di mercato maggiore nel 2021. Inoltre, si prevede che il segmento dei servizi di metabolomica mirato registrerà un CAGR più elevato nel mercato durante il periodo di previsione.
Mercato dei servizi di metabolomica, per tipo di servizio: 2021 e 2028
Approfondimenti basati sull'applicazione
Il mercato dei servizi di metabolomica, in base all'applicazione, è segmentato nell’industria farmaceutica e biotecnologica, nell’agritech e nell’ambiente. È probabile che il segmento dell'industria farmaceutica e biotecnologica deterrà la quota maggiore del mercato nel 2021. Inoltre, si prevede che il mercato per questo segmento crescerà al CAGR più rapido del 21,6% nel periodo dal 2021 al 2028.
  ;
Gli operatori del mercato dei servizi di metabolomica adottano strategie organiche come il lancio e l'espansione del prodotto per espandere la propria presenza globale e il portafoglio di prodotti.
Per tipo di servizio
- Servizio di metabolomica mirata
- Servizio di metabolomica non mirata
Per applicazione
- Industria farmaceutica e biotecnologica
- Scoperta di biomarcatori
- Scoperta di farmaci
- Test tossicologici
- Altro
- Agritech
- Ambiente
Per geografia< /h3>- Nord America
- Stati Uniti
- Canada
- Messico
- Europa
- Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto d'Europa< /li>
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- America centrale e meridionale (SCAM)
- Brasile
- Argentina
- Resto dello SCAM
Profili aziendali
- BASF SE
- TMIC
- Proteomica creativa
- BGI
- RTI Internazionale
- Afekta Technologies Ltd.
- Centro di ricerca sul cancro Fred Hutchinson
- Centro di metabolomica della costa occidentale
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
- Stati Uniti
- Canada
- Messico
- Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto d'Europa< /li>
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- Brasile
- Argentina
- Resto dello SCAM
Profili aziendali
- BASF SE
- TMIC
- Proteomica creativa
- BGI
- RTI Internazionale
- Afekta Technologies Ltd.
- Centro di ricerca sul cancro Fred Hutchinson
- Centro di metabolomica della costa occidentale
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
BASF SE and TMIC .are the key players in the Metabolomics Services market
Targeted metabolomics service segment market provides the most opportunity for growth
The Metabolomics Services market is anticipated to grow around 20.9% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2021.
Key factors that are driving growth of the market are rising incidences of cancer and increasing adoption of metabolomics and investments by market players. However, high cost of tools, instruments, and usage is expected to restrict the market growth during the forecast period.
Metabolomics is the study and analysis of biological processes involving metabolic intermediates and byproducts. These products are referred to as metabolomes, and they contain all metabolites involved in an organism's many processes, including secondary metabolites, signalling molecules, hormones, and metabolic intermediates.
The List of Companies - Metabolomics Services Market
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
- Afekta Technologies Ltd.
- Fred Hutchinson Cancer Research Center
- West Coast Metabolomics Center
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Oct 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Oct 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Oct 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)